We are live on ! Find out more
CIR

Clear Investment Research Portfolio holdings

AUM $63.9M
1-Year Est. Return 11.37%
This Fund
S&P 500
This Quarter Est. Return
+2.68%
1 Year Est. Return
+11.37%
3 Year Est. Return
+37.84%
5 Year Est. Return
+37.18%
10 Year Est. Return
+103.92%
AUM
$147M
AUM Growth
+$16.2M
Cap. Flow
+$12.3M
Cap. Flow %
8.37%
Top 10 Hldgs %
73.53%
Holding
57
New
2
Increased
22
Reduced
13
Closed
1

Sector Composition

Rank Sector Weight
1 Financials 0.39%
2 Healthcare 0.15%
3 Industrials 0.15%
4 Consumer Discretionary 0.09%
5 Consumer Staples 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VNQ icon
26
Vanguard Real Estate ETF
VNQ
$39.2B
$393K 0.27%
4,727
+199
+4% +$16.6K
SCHM icon
27
Schwab US Mid-Cap ETF
SCHM
$14.5B
$390K 0.26%
23,337
SCHV
28
Schwab US Large-Cap Value ETF
SCHV
$15.7B
$316K 0.21%
18,312
ACWX icon
29
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
$302K 0.21%
6,237
-238
-4% -$11.2K
LDUR icon
30
PIMCO Enhanced Low Duration Active Exchange-Traded Fund
LDUR
$1.37B
$283K 0.19%
2,799
+98
+4% +$9.9K
SCHA icon
31
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$249K 0.17%
14,760
-260
-2% -$4.18K
SCHG icon
32
Schwab US Large-Cap Growth ETF
SCHG
$59.8B
$246K 0.17%
29,768
HYS icon
33
PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund
HYS
$1.75B
$241K 0.16%
2,376
+75
+3% +$7.59K
LLY icon
34
Eli Lilly
LLY
$1.02T
$223K 0.15%
2,636
-611
-19% -$50.1K
R icon
35
Ryder
R
$9.83B
$223K 0.15%
2,636
DJP icon
36
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$800M
$146K 0.1%
6,259
-1,645
-21% -$37.9K
SCHZ icon
37
Schwab US Aggregate Bond ETF
SCHZ
$10.5B
$137K 0.09%
5,218
SCHE icon
38
Schwab Emerging Markets Equity ETF
SCHE
$12.6B
$128K 0.09%
4,755
SCHH icon
39
Schwab US REIT ETF
SCHH
$11.5B
$125K 0.08%
6,054
+212
+4% +$4.37K
WFC icon
40
Wells Fargo
WFC
$261B
$120K 0.08%
2,184
SPLV icon
41
Invesco S&P 500 Low Volatility ETF
SPLV
$7.12B
$117K 0.08%
+2,550
New +$116K
AMZN icon
42
Amazon
AMZN
$2.92T
$115K 0.08%
14,640
SCHC icon
43
Schwab International Small-Cap Equity ETF
SCHC
$5.39B
$99K 0.07%
2,932
PG icon
44
Procter & Gamble
PG
$336B
$82K 0.06%
896
WP
45
DELISTED
Worldpay, Inc.
WP
$80K 0.05%
1,139
FBND icon
46
Fidelity Total Bond ETF
FBND
$26.9B
$21K 0.01%
+419
New +$21.1K
GPK icon
47
Graphic Packaging
GPK
$3.17B
$21K 0.01%
1,536
GOVT icon
48
iShares US Treasury Bond ETF
GOVT
$43.6B
$16K 0.01%
653
-549
-46% -$13.9K
IEMG icon
49
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
$14K 0.01%
267
+70
+36% +$3.71K
SHY icon
50
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
$10K 0.01%
123
-102
-45% -$8.62K

Similar funds

Clear Investment Research's Q3 2017 Portfolio in Review

As of Q3 2017, Clear Investment Research held 57 positions worth $147M, up 12% from $131M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Clear Investment Research deployed $12.3M of net new capital in Q3 2017, opening 2 new positions and adding to 22 existing holdings. Its largest new stake was Invesco S&P 500 Low Volatility ETF: 2,550 shares worth $117K.

By sector, the portfolio is most concentrated in Financials at 0.39% of assets, down from 0.42% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was iShares Core US Aggregate Bond ETF, an estimated $4.23M trimmed.

  • Clear Investment Research's largest Q3 2017 buy was Invesco S&P 500 Low Volatility ETF: 2,550 shares worth $117K.
  • Clear Investment Research added most to iShares Core MSCI EAFE ETF in Q3 2017, an estimated $4.67M increase.
  • Clear Investment Research's biggest Q3 2017 reduction was iShares Core US Aggregate Bond ETF, cutting an estimated $4.23M.
  • Clear Investment Research fully exited iShares Silver Trust in Q3 2017, selling an estimated $7K.
  • Clear Investment Research's ten largest holdings make up 74% of its $147M portfolio in Q3 2017.
  • Clear Investment Research opened 2 new positions and closed 1 in Q3 2017.
  • Clear Investment Research's portfolio value rose 12% quarter-over-quarter to $147M.

Based on Clear Investment Research's 13F filing for Q3 2017, filed 30 Oct 2017.